Blood component therapyDiSaia and Creasman Clinical Gynecologic OncologyJanuary 2, 2024Obstetrics and Gynecology You're Reading a Preview Become a Clinical Tree membership for Full access and enjoy Unlimited articles Become membership If you are a member. Log in here Previous Post Modified from common terminology criteria for adverse events (Common Terminology Criteria for Adverse Events) Next Post Suggested recommendations for routine cancer screening
Suggested recommendations for routine cancer screening DiSaia and Creasman Clinical Gynecologic Oncology
Modified from common terminology criteria for adverse events (Common Terminology Criteria for Adverse Events) DiSaia and Creasman Clinical Gynecologic Oncology